Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1CNS 1

Conditions

Obesity 1Craniopharyngioma 1

Interventions

Exenatide 3Temozolomide 2Surgical Procedures, Operative 2Mental Status and Dementia Tests 2Donepezil 2tozuleristide 1temsirolimus 1entinostat 1carboxyamido-triazole 1antineoplaston AS 2-1 1antineoplaston A10 1Thalidomide 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiation 1Psychiatric Rehabilitation 1Photochemotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Oxytocin 1Memantine 1Medication Errors 1Irinotecan 1Ginkgo biloba extract 1Fentanyl 1Docetaxel 1Dihematoporphyrin Ether 1Diazoxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Craniopharyngioma × CKD732 × Clear all
NCT02063295 2016-07-18

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Zafgen, Inc.

Phase 2 Completed
14 enrolled
CNSOther

Craniopharyngioma, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡